ATE445013T1 - Polypeptide und deren dna - Google Patents
Polypeptide und deren dnaInfo
- Publication number
- ATE445013T1 ATE445013T1 AT00942387T AT00942387T ATE445013T1 AT E445013 T1 ATE445013 T1 AT E445013T1 AT 00942387 T AT00942387 T AT 00942387T AT 00942387 T AT00942387 T AT 00942387T AT E445013 T1 ATE445013 T1 AT E445013T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- salts
- compounds
- present
- screening
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physical Education & Sports Medicine (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18671899 | 1999-06-30 | ||
PCT/JP2000/004278 WO2001002564A1 (fr) | 1999-06-30 | 2000-06-29 | Nouveau polypeptide et adn de ce polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE445013T1 true ATE445013T1 (de) | 2009-10-15 |
Family
ID=16193433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00942387T ATE445013T1 (de) | 1999-06-30 | 2000-06-29 | Polypeptide und deren dna |
Country Status (12)
Country | Link |
---|---|
US (1) | US6797483B1 (de) |
EP (1) | EP1191099B1 (de) |
KR (1) | KR20020026465A (de) |
CN (1) | CN1359421A (de) |
AT (1) | ATE445013T1 (de) |
AU (1) | AU5705600A (de) |
CA (1) | CA2377791A1 (de) |
DE (1) | DE60043106D1 (de) |
HU (1) | HUP0201660A2 (de) |
NO (1) | NO20016344L (de) |
PL (1) | PL353065A1 (de) |
WO (1) | WO2001002564A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030166525A1 (en) | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
WO2001055332A2 (en) * | 2000-01-25 | 2001-08-02 | Hyseq, Inc. | Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
AU2003250547A1 (en) * | 2002-08-05 | 2004-02-23 | Asahi Kasei Kabushiki Kaisha | Cartilage differentiation inhibiting gene |
WO2004015078A2 (en) * | 2002-08-08 | 2004-02-19 | Nuvelo, Inc. | Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
DK1610822T4 (en) | 2003-04-02 | 2019-01-14 | Ares Trading Sa | Liquid pharmaceutical FSH and LH formulations together with a nonionic surfactant |
CA2526099C (en) | 2003-06-20 | 2013-02-05 | Ares Trading Sa | Freeze-dried fsh / lh formulations |
JP6976254B2 (ja) * | 2015-09-18 | 2021-12-08 | バイオネット ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツングBioNet Pharma GmbH | Cd−rap前駆体タンパク質の使用による、cd−rapの製造方法における発現およびフォールディングの改善 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0710248T3 (da) * | 1993-07-20 | 2000-04-10 | Roche Diagnostics Gmbh | Melanom-inhiberende protein |
AU6030398A (en) * | 1997-01-21 | 1998-08-07 | Auckland Uniservices Limited | Human proteins |
JP2003525568A (ja) * | 1997-12-20 | 2003-09-02 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | 分泌蛋白およびそれらをコードするポリヌクレオチド |
AU2225401A (en) * | 1999-12-27 | 2001-07-09 | Takeda Chemical Industries Ltd. | Novel protein and dna thereof |
WO2001055332A2 (en) * | 2000-01-25 | 2001-08-02 | Hyseq, Inc. | Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
JP6623690B2 (ja) | 2015-10-30 | 2019-12-25 | 味の素株式会社 | グルタミン酸系l−アミノ酸の製造法 |
-
2000
- 2000-06-29 EP EP00942387A patent/EP1191099B1/de not_active Expired - Lifetime
- 2000-06-29 AU AU57056/00A patent/AU5705600A/en not_active Abandoned
- 2000-06-29 DE DE60043106T patent/DE60043106D1/de not_active Expired - Lifetime
- 2000-06-29 CN CN00809843A patent/CN1359421A/zh active Pending
- 2000-06-29 WO PCT/JP2000/004278 patent/WO2001002564A1/ja not_active Application Discontinuation
- 2000-06-29 AT AT00942387T patent/ATE445013T1/de not_active IP Right Cessation
- 2000-06-29 PL PL00353065A patent/PL353065A1/xx unknown
- 2000-06-29 US US10/019,455 patent/US6797483B1/en not_active Expired - Fee Related
- 2000-06-29 KR KR1020017016470A patent/KR20020026465A/ko not_active Application Discontinuation
- 2000-06-29 CA CA002377791A patent/CA2377791A1/en not_active Abandoned
- 2000-06-29 HU HU0201660A patent/HUP0201660A2/hu unknown
-
2001
- 2001-12-21 NO NO20016344A patent/NO20016344L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU5705600A (en) | 2001-01-22 |
EP1191099A1 (de) | 2002-03-27 |
EP1191099A4 (de) | 2002-08-07 |
KR20020026465A (ko) | 2002-04-10 |
WO2001002564A1 (fr) | 2001-01-11 |
CN1359421A (zh) | 2002-07-17 |
NO20016344L (no) | 2002-02-19 |
DE60043106D1 (de) | 2009-11-19 |
PL353065A1 (en) | 2003-10-06 |
CA2377791A1 (en) | 2001-01-11 |
HUP0201660A2 (en) | 2002-08-28 |
NO20016344D0 (no) | 2001-12-21 |
EP1191099B1 (de) | 2009-10-07 |
US6797483B1 (en) | 2004-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE364698T1 (de) | Neues, physiologisch aktives peptid und dessen verwendung | |
DE60037836D1 (de) | ThiazoloÄ4,5-dÜpyrimidinverbindungen zur Behandlung von rheumathoider Arthritis | |
DE69929996D1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
WO2000047568A3 (en) | 1,2-benzothiazepines for the treatment of hyperlipidemic diseases | |
DE69725556D1 (de) | Flüssige, orale zusammensetzung, welche eine kalziumverbindung und eine säure enthält | |
DK15589D0 (da) | Kemiske forbindelser | |
NO302474B1 (no) | Sakarinderivater, farmasöytisk sammensetning og anvendelse derav | |
DK2157192T3 (da) | Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner) | |
ATE311380T1 (de) | Durch säuregruppen disubstitierte heteroaryl- derivate und ihre verwendung als matrix metalloproteinas inhibitoren | |
MA26608A1 (fr) | Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque. | |
KR870700599A (ko) | 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도 | |
DE69531004D1 (de) | p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES | |
SG121733A1 (en) | Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease | |
SE9804212D0 (sv) | Compounds | |
WO2001064877A3 (en) | Human schizophrenia gene | |
DE60043106D1 (de) | Polypeptide und deren dna | |
BR0211635A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um indivìduo sofrendo de ou propenso à doença de alzheimer | |
DK383388A (da) | 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling | |
BR9811821A (pt) | 2-acilaminopropanaminas como antagonistas de receptores de taquicinina | |
WO2001064876A3 (en) | Human schizophrenia gene | |
DK0552765T3 (da) | benzimidazoler, farmaceutiske præparater indeholdende disse og fremgangsmåde til deres fremstilling | |
EP0915087A3 (de) | Sulfonamid-substituierte anellierte 5-Ring-Verbindungen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen | |
EP0913396A3 (de) | Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen | |
WO2002062944A3 (fr) | Nouveau peptide physiologiquement actif et son utilisation | |
DK412388D0 (da) | Leukotrienantagonister, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse som laegemidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |